Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

LONDON MARKET CLOSE: Vodafone lifts FTSE 100 as easyJet backs new bid

10th Jul 2026 17:05

(Alliance News) - The FTSE 100 closed higher on Friday in calmer trading, boosted by double-digit gains from telecommunications firm Vodafone. Read More

WINNERS & LOSERS: Vodafone and easyJet jump on deal activity

10th Jul 2026 10:30

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble

10th Jul 2026 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback

9th Jul 2026 17:09

(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the Middle East. Read More

LONDON MARKET MIDDAY: FTSE 100 misses out on rebound as Astra drops

9th Jul 2026 11:56

(Alliance News) - Stock prices in London were mixed at midday on Thursday, with the FTSE 100 underperforming its European peers as a sharp fall in AstraZeneca outweighed gains elsewhere, while investors continued to monitor developments in the Middle East. Read More

WINNERS & LOSERS: Astra down on failed test; Computacenter ups outlook

9th Jul 2026 10:33

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

LONDON MARKET OPEN: FTSE 100 lags Europe as AstraZeneca sinks

9th Jul 2026 09:28

(Alliance News) - Stock prices in London opened lower on Thursday, with the FTSE 100 lagging behind its European peers as a sharp fall in AstraZeneca overshadowed gains elsewhere in the market. Read More

AstraZeneca shares fall 9% as cardiovascular drug Wainua fails test

9th Jul 2026 08:58

(Alliance News) - AstraZeneca PLC on Thursday said Wainua, a cardiovascular drug that it is developing in partnership with Ionis Pharmaceuticals Inc, did not meet its primary endpoint in a phase III trial. Read More

PRESS: AstraZeneca and Daiichi near UK Enhertu price deal - Bloomberg

8th Jul 2026 13:34

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd are progressing towards a deal which could bring access to breast cancer drug Enhertu for some patients in England and Wales, Bloomberg reported on Wednesday. Read More

LONDON BROKER RATINGS: JPMorgan cuts ITV to neutral after Sky deal

7th Jul 2026 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON MARKET CLOSE: Stocks mixed as weak miners weigh in muted trade

6th Jul 2026 17:07

(Alliance News) - The FTSE 100 gave back early gains on Monday as falls in gold miners and AstraZeneca, plus soft construction figures, dampened early enthusiasm. Read More

LONDON BROKER RATINGS: HSBC raises GSK; RBC cuts Close Brothers

6th Jul 2026 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday : Read More

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

2nd Jul 2026 17:04

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike across the pond. Read More

Hutchmed drug approved in China for advanced gastric cancer

2nd Jul 2026 14:26

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer with "a very poor prognosis". Read More

WINNERS & LOSERS: PPHE Hotel ends sales process; CMC Markets rises

2nd Jul 2026 10:21

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

LONDON BROKER RATINGS: Deutsche ups RS to buy; Exane neutral on Segro

1st Jul 2026 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

AstraZeneca's Enhertu wins first EU tumour-agnostic approval for HER2

29th Jun 2026 08:38

(Alliance News) - AstraZeneca PLC on Monday said the European Commission has approved Enhertu as the first tumour-agnostic HER2-directed therapy and antibody drug conjugate in the EU for previously treated patients with HER2-positive metastatic solid tumours. Read More

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

29th Jun 2026 07:57

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts. Read More

AstraZeneca's, Daiichi's Datroway recommended for further EU approval

26th Jun 2026 12:32

(Alliance News) - AstraZeneca PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of Datroway for a form of breast cancer. Read More

LONDON MARKET CLOSE: Miners peg back FTSE 100 while mid-caps struggle

23rd Jun 2026 16:59

(Alliance News) - The FTSE 100 edged lower on Tuesday held back by weak miners, while fresh US tech falls and soft UK economic data added to the muted mood. Read More

FTSE 100 Latest
Value10,506.58
Change-44.59